Stonepine Capital Management, LLC

Holdings History for Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Symbol: QNRX on Nasdaq
Investment type: Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Latest Disclosed Shares Owned: 3,271,100 shares
Security Ownership %: 11%

Shares, Excluding Options vs Price

Value, Excluding Options

Stonepine Capital Management, LLC ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

02 Feb 2026 - Stonepine Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,271,100 shares of Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 11% ownership of the company. In their previous filing dated 16 Dec 2025, Stonepine Capital Management, LLC had reported owning 3,030,926 shares, indicating an increase of +7.9%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Stonepine Capital Management, LLC	11%	+7%	$47,201,973	3,271,100	+240,174	+7.9%	$14.43	13G/A	29 Jan 2026	02 Feb 2026, 20:01
Stonepine Capital Management, LLC	9.9%		$62,800,787	3,030,926			$20.72	13G	10 Dec 2025	16 Dec 2025, 16:04

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.9%	+0.9%	$1,128,267	78,189	+78,189	NEW	$14.43	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.